Georges Gemayel - Feb 19, 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
Feb 19, 2025
Transactions value $
$0
Form type
4
Date filed
2/21/2025, 04:49 PM
Previous filing
Nov 12, 2024
Next filing
Feb 24, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 13.3K Feb 19, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Director Stock Option (Right to Buy) Award $0 +7.3K $0.00 7.3K Feb 19, 2025 Common Stock 7.3K $33.52 Direct F1
transaction SUPN Restricted Stock Unit Award $0 +4.48K $0.00 4.48K Feb 19, 2025 Common Stock 4.48K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on February 19, 2026.
F2 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F3 These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026.